Innovative Approach to Reduce Lung Cancer Stigma
This is a feasibility study examining the feasibility and acceptability of a novel psychotherapy intervention on lung cancer patients who are experiencing stigma.
Checked against the public recordLast updated Jul 28, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Arizona
- Interventions being studied
- Behavioral: ACT-LCS Therapy
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Proficiency in English * Diagnosed with or treated for Non-Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) within the prior 12 months. * Scores of 37.5 on the Lung Cancer Stigma Inventory (LCSI) screening measure Exclusion Criteria: * Not proficient in English
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Arizona Cancer CenterTucson, Arizona
- Memorial Sloan Kettering Cancer CenterNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 28, 2022. Always confirm current availability with the study team.